コネチカット州における骨髄異形成症候群の臨床試験
コネチカット州内の拠点で、骨髄異形成症候群に関する10件の研究が参加者を募集しています。
コネチカット州内の都市
公式研究テキスト（英語）
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Yale University, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06484062MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05564390A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Yale, New Haven
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07422480The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Connecticut Children's Medical Center, Hartford
- Yale University, New Haven
被験者募集中第1/2相
22歳以下 · 全性別 · 2026/08/25更新 · NCT04726241A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Smilow Cancer Hospital at Yale-New Haven, New Haven
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06499285ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- Yale University, Yale Cancer Center, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT06656494Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
- Connecticut Children's Medical Center, Hartford
被験者募集中観察研究
30歳以下 · 全性別 · 2026/07/16更新 · NCT04968834A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
- GSK Investigational Site, New Haven
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/02更新 · NCT06847867A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Yale University, New Haven
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/04/30更新 · NCT04256317SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。